It is called a specific therapy mainly because it exclusively targets the CD38  which might be overexpressed around the multiple myeloma cells. Daratumumab is from a class of medicines identified as CD38 monoclonal antibodies. copyright and Wegovy have distinct FDA-approved uses, which is an important difference For several causes. The two medici